|
GPR89A expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.792200E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.378000E-02 |
| Normal-vs-Stage2 |
5.526400E-01 |
| Normal-vs-Stage3 |
4.425900E-02 |
| Normal-vs-Stage4 |
9.114400E-02 |
| Stage1-vs-Stage2 |
4.982800E-01 |
| Stage1-vs-Stage3 |
6.012200E-01 |
| Stage1-vs-Stage4 |
8.359400E-01 |
| Stage2-vs-Stage3 |
3.581800E-01 |
| Stage2-vs-Stage4 |
4.703000E-01 |
| Stage3-vs-Stage4 |
8.615200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.106280E-02 |
| Normal-vs-AfricanAmerican |
7.620600E-01 |
| Normal-vs-Asian |
3.731400E-01 |
| Caucasian-vs-AfricanAmerican |
2.462000E-01 |
| Caucasian-vs-Asian |
2.585400E-01 |
| AfricanAmerican-vs-Asian |
7.655800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.150200E-02 |
| Normal-vs-Female |
4.307800E-02 |
| Male-vs-Female |
9.688000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.964300E-02 |
| Normal-vs-Age(41-60Yrs) |
1.369590E-02 |
| Normal-vs-Age(61-80Yrs) |
3.508800E-01 |
| Normal-vs-Age(81-100Yrs) |
8.086600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.779800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.558600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.803800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.569840E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.463200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.333600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.030110E-02 |
| Classical-VS-Follicular |
4.915000E-01 |
| Classical-VS-Other |
4.906000E-01 |
| Classical-VS-Normal |
1.460970E-01 |
| Tall-VS-Follicular |
5.801200E-03 |
| Tall-VS-Other |
4.968000E-01 |
| Tall-VS-Normal |
6.369500E-04 |
| Follicular-VS-Other |
4.351200E-01 |
| Follicular-VS-Normal |
5.027200E-01 |
| Other-VS-Normal |
1.520200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.869360E-01 |
| Normal-vs-N1 |
1.777930E-02 |
| N0-vs-N1 |
1.209440E-01 |
|
|
